Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00746304|
Recruitment Status : Completed
First Posted : September 3, 2008
Last Update Posted : September 3, 2008
|Condition or disease|
Participants: 164 patients with infantile esotropia and 89 patients with acquired esotropia.
Methods: Patients were injected with botulinum toxin into two medial rectus muscles and followed from 1992 to 2005. Patients were evaluated at 1 week, 2, 6 and 12 months, and then yearly post-injection.
Main Outcome Measures: Degree of motor alignment, recurrence rate, incidence of stereopsis, and dissociated vertical deviation along with complications.
|Study Type :||Observational|
|Actual Enrollment :||164 participants|
|Official Title:||Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin|
|Study Start Date :||September 2007|
|Actual Primary Completion Date :||October 2007|
|Actual Study Completion Date :||December 2007|
- Degree of motor alignment, recurrence rate, incidence of stereopsis, and dissociated vertical deviation along with complications. [ Time Frame: Before treatment, weekly after the treatment, and monthly after motor alignment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00746304
|National Taiwan University Hospital|
|Taipei, Taiwan, 100|
|Principal Investigator:||Tzu-Hsun Tsai, MD||National Taiwan University Hospital|